Award recordCONTRACT

QIAGEN, LLC

PIID 36C24822P1535· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6640 · LABORATORY EQUIPMENT AND SUPPLIES· FY2022· $454,497 net obligations· UEI W2GLKC92ZH73· MD

Description

DE-OBLIGATE EXCESS FUNDS

Base award description: QIAGEN REAGENTS

First action · last action
2022-07-28 · 2026-08-10
Transactions
15
First transaction's obligation
$24,394
Base + all options value (sum of deltas)
$599,158
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 15 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$490,745$0Base award · 2022-07-28 · this action $24,394 · running total $24,394Modification P00001 · 2022-09-22 · this action $0 · running total $24,394Modification P00002 · 2022-10-01 · this action $44,044 · running total $68,438Modification P00003 · 2023-03-27 · this action -$12,834 · running total $55,604Modification P00004 · 2023-10-01 · this action $44,702 · running total $100,306Modification P00005 · 2023-10-05 · this action $97,658 · running total $197,964Modification P00006 · 2023-10-11 · this action $0 · running total $197,964Modification P00007 · 2023-12-15 · this action -$190 · running total $197,774Modification P00008 · 2024-08-08 · this action $3,897 · running total $201,671Modification P00009 · 2024-10-01 · this action $144,525 · running total $346,196Modification P00010 · 2024-12-13 · this action -$112 · running total $346,084Modification P00011 · 2025-10-01 · this action $144,661 · running total $490,745Modification P00012 · 2026-04-15 · this action -$50,970 · running total $439,775Modification P00013 · 2026-06-09 · this action -$232 · running total $439,543Modification P00014 · 2026-08-10 · this action $14,954 · running total $454,497
  • Base2022-07-28+$24,394= $24,394
  • Mod P000012022-09-22+$0= $24,394
  • Mod P000022022-10-01+$44,044= $68,438
  • Mod P000032023-03-27-$12,834= $55,604
  • Mod P000042023-10-01+$44,702= $100,306
  • Mod P000052023-10-05+$97,658= $197,964
  • Mod P000062023-10-11+$0= $197,964
  • Mod P000072023-12-15-$190= $197,774
  • Mod P000082024-08-08+$3,897= $201,671
  • Mod P000092024-10-01+$144,525= $346,196
  • Mod P000102024-12-13-$112= $346,084
  • Mod P000112025-10-01+$144,661= $490,745
  • Mod P000122026-04-15-$50,970= $439,775
  • Mod P000132026-06-09-$232= $439,543
  • Mod P000142026-08-10+$14,954= $454,497
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-07-28+$24,394$24,394QIAGEN REAGENTS
Mod P00001· EXERCISE AN OPTION2022-09-22+$0$24,394EXERCISE OPTION YEAR 1, SUBJECT TO AVAILABILITY OF FUNDS
Mod P00002· EXERCISE AN OPTION2022-10-01+$44,044$68,438EXERCISE OPTION YEAR 1, FUNDED
Mod P00003· FUNDING ONLY ACTION2023-03-27−$12,834$55,604EXERCISE OPTION YEAR 1, FUNDED
Mod P00004· EXERCISE AN OPTION2023-10-01+$44,702$100,306EXERCISE OPTION YEAR 1, FUNDED
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-10-05+$97,658$197,964EXERCISE OPTION YEAR 1, FUNDED
Mod P00006· OTHER ADMINISTRATIVE ACTION2023-10-11+$0$197,964EXERCISE OPTION YEAR 1, FUNDED
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-12-15−$190$197,774EXERCISE OPTION YEAR 1, FUNDED
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-08-08+$3,897$201,671EXERCISE OPTION YEAR 1, FUNDED
Mod P00009· EXERCISE AN OPTION2024-10-01+$144,525$346,196EXERCISE OPTION YEAR 3
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-13−$112$346,084EXERCISE OPTION YEAR 3
Mod P00011· EXERCISE AN OPTION2025-10-01+$144,661$490,745EXERCISE OPTION YEAR 3
Mod P00012· FUNDING ONLY ACTION2026-04-15−$50,970$439,775DE-OBLIGATE EXCESS FUNDS
Mod P00013· OTHER ADMINISTRATIVE ACTION2026-06-09−$232$439,543DE-OBLIGATE EXCESS FUNDS
Mod P00014· OTHER ADMINISTRATIVE ACTION2026-08-10+$14,954$454,497DE-OBLIGATE EXCESS FUNDS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI W2GLKC92ZH73)

AwardOffice · PSC / listingNet obligationsFY
36C25926N0353NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$88,310FY2026
36C25526N0349255-NETWORK CONTRACT OFFICE 15 (36C255) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$93,253FY2026
36C26226P0924262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$161,777FY2026
36C24126P0433241-NETWORK CONTRACT OFFICE 01 (36C241) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES$15,157FY2026
36C26126P0408261-NETWORK CONTRACT OFFICE 21 (36C261) · H266 · EQUIPMENT AND MATERIALS TESTING- INSTRUMENTS AND LABORATORY EQUIPMENT$15,157FY2026
36C25026P0365250-NETWORK CONTRACT OFFICE 10 (36C250) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES$18,264FY2026

Other recipients under 6640 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826A0029ABBOTT LABORATORIES INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$0FY2026
36C24826N0821ABBOTT LABORATORIES INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$289,849FY2026
36C24826P1068CEPHEID248-NETWORK CONTRACT OFFICE 8 (36C248)$63,150FY2026
36C24826P1104HOLOGIC SALES AND SERVICE, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$263,800FY2026
36C24826P1126TRILLAMED LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$25,838FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24822P1535_3600_-NONE-_-NONE- · retrieved 2026-09-26.